BURLINGTON, Mass., June 1 /PRNewswire-FirstCall/ -- Palomar Medical
Technologies Inc (Nasdaq: PMTI), a leading researcher and developer of light-
based systems for cosmetic treatments, today announced some of its products
were featured on ABC Daytime Television's Talk Show "The View" in yesterday's
episode titled "The Cutting Edge of Beauty." Arielle Kauvar MD, a Director at
New York Laser and Skin Care Center, joined co-hosts Barbara Walters, Meredith
Vieira, Star Jones Reynolds, Joy Behar, and Elisabeth Hasselbeck as they
examined the latest cosmetic treatments and beauty secrets of the stars.
Featuring new technology capable of addressing multiple cosmetic applications,
Dr. Kauvar highlighted one of Palomar's light-based aesthetic platforms, the
StarLux, and its corresponding interchangeable laser handpiece, the Lux1064,
for the treatment and removal of varicose veins. Live digital footage was
provided to audience members to observe the actual closings of vessels
instantaneously.
Commenting on Palomar's inclusion on "The View," Palomar Chief Executive
Officer, Joseph P. Caruso said, "Following our ranking as number four in
BusinessWeek's 'Top 100 Hot Growth Companies,' exposure on 'The View' not only
reaffirms our position in the marketplace, but also highlights the recent
surge in consumer interest for noninvasive cosmetic treatments. This type of
exposure to the masses will fuel demand for these types of new cosmetic light
based procedures that are still virtually unknown to the general population.
"This episode featured the removal of veins. Palomar's proprietary
technology provides dramatic improvement of veins in just one painless
treatment. Our technology is also capable of addressing multiple cosmetic
applications through multi-use, versatile and cost effective platforms
including permanent hair removal, photofacials through the removal of vascular
and pigmented lesions, and acne. The increasing exposure on Palomar validates
our leadership in technology and in the aesthetic market with results that can
only be achieved using light based treatments. We are pleased that our
products are being recognized by the medical community as safe, effective
systems capable of high end results and satisfied customers."
"The View," is a recipient of the 2003 Daytime Emmy Award for "Outstanding
Talk Show" and is produced by ABC News correspondent Barbara Walters. Deemed
ABC Daytime's 'morning chat fest,' "The View" features a team of five dynamic
women of different ages, experiences and backgrounds discussing the most
exciting events of the day. Many of the topics discussed consist of recent
events in the news, top trends and experts in the field, celebrity interviews
and general entertainment. The program celebrated its 1500th show on January
23, 2004 and is currently in its seventh season.
About Palomar Medical Technologies Inc: Palomar is a leading researcher
and developer of light-based systems for cosmetic treatments. Palomar
pioneered the optical hair removal field, when, in 1997, it introduced the
first high-powered laser hair removal system. Since then, many of the major
advances in light-based hair removal have been based on Palomar technology.
There are now millions of light-based cosmetic procedures performed around the
world every year in physician offices, clinics, spas and salons. Palomar is
testing many new and exciting indications to further advance the hair removal
market and other cosmetic applications. Palomar is uniquely focused on
developing proprietary light-based technology for introduction to the mass
markets. Palomar has an agreement with The Gillette Company (NYSE: G) to
develop and potentially commercialize a patented home-use, light-based hair
removal device for women, and an agreement with Johnson & Johnson Consumer
Companies to develop and potentially commercialize home-use, light-based
devices for reducing or reshaping body fat including cellulite, reducing the
appearance of skin aging, and reducing or preventing acne. For more
information on Palomar and its products, visit Palomar's website at
http://www.palomarmedical.com. To continue receiving the most up-to-date
information and latest news on Palomar as it happens, sign up to receive
automatic e-mail alerts by going to the E-mail Alerts page in the Investor
Relations' section of the website.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, challenges in managing joint ventures and
research with third parties and government contracts, the impact of
competitive products and pricing, governmental regulations with respect to
medical devices, including whether FDA clearance will be obtained for future
products, the results of litigation, difficulties in collecting royalties,
potential infringement of third-party intellectual property rights, and/or
other factors, which are detailed from time to time in the Company's SEC
reports, including the report on Form 10-K for the year ended December 31,
2004 and the Company's quarterly reports on Form 10-Q. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. The Company undertakes no obligation to release
publicly the result of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Contacts: Investor Relations
Palomar Medical Technologies Inc
781-993-2411
ir@palomarmedical.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Investor Relations of Palomar Medical
Technologies Inc, +1-781- 993-2411, ir@palomarmedical.com
|
